Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Tag: SOP change control

Using Impact Assessment Tools During SOP Updates

Posted on By

Using Impact Assessment Tools During SOP Updates How to Use Impact Assessment Tools When Updating SOPs Standard Operating Procedure (SOP) updates are not just editorial tasks in the pharmaceutical industry—they are part of a tightly controlled compliance framework. Every revision must undergo impact assessment to evaluate the risks and changes involved. In this tutorial, we…

Read More “Using Impact Assessment Tools During SOP Updates” »

SOP Guidelines, SOP Revision Processes

GMP Risk from SOP Changes Without Corresponding Validation Updates

Posted on By

GMP Risk from SOP Changes Without Corresponding Validation Updates Ensuring SOP Changes Reflect Validation Data for GMP Compliance Introduction to the Audit Finding 1. What’s the Problem? Standard Operating Procedures (SOPs) are sometimes revised to reflect process changes or improvements. However, these changes may not be supported by corresponding validation activities — creating a gap…

Read More “GMP Risk from SOP Changes Without Corresponding Validation Updates” »

Change Control Linkage, GMP Audit Findings

When and Why Should SOPs Be Revised?

Posted on By

When and Why Should SOPs Be Revised? Understanding the Timing and Triggers for SOP Revisions Standard Operating Procedures (SOPs) are the backbone of quality assurance in the pharmaceutical industry. However, their value depends entirely on their relevance and accuracy. An outdated SOP is more dangerous than none—it creates a false sense of compliance. This tutorial…

Read More “When and Why Should SOPs Be Revised?” »

SOP Guidelines, SOP Revision Processes

Ensuring GMP Through Formal Review Procedures for Vendor SOP Updates

Posted on By

Ensuring GMP Through Formal Review Procedures for Vendor SOP Updates Establishing Robust Procedures for Vendor SOP Updates Review in GMP Systems Introduction to the Audit Finding 1. The Gap Explained This audit finding highlights the absence of a documented process for reviewing updated SOPs received from vendors or third-party service providers. 2. GMP Relevance In…

Read More “Ensuring GMP Through Formal Review Procedures for Vendor SOP Updates” »

GMP Audit Findings, Third-Party SOPs

Writing Emergency and Deviation Handling SOPs

Posted on By

Writing Emergency and Deviation Handling SOPs How to Develop Effective SOPs for Emergency and Deviation Management Unexpected events in pharmaceutical environments—from power outages to batch deviations—can occur at any moment. The key to regulatory compliance and patient safety lies in how well these deviations and emergencies are documented and handled. Standard Operating Procedures (SOPs) that…

Read More “Writing Emergency and Deviation Handling SOPs” »

SOP Development, SOP Guidelines

Staff Unaware of Recent SOP Changes: A Compliance and Training Risk

Posted on By

Staff Unaware of Recent SOP Changes: A Compliance and Training Risk Failure to Communicate SOP Revisions to Staff: A Hidden Compliance Risk Introduction to the Audit Finding 1. SOP Revisions Not Communicated Staff continued following outdated SOPs due to lack of communication of recent changes. 2. Training Logs Incomplete No documented evidence that employees were…

Read More “Staff Unaware of Recent SOP Changes: A Compliance and Training Risk” »

GMP Audit Findings, SOP Training Failure

Understanding the Lifecycle of an SOP Document in Pharma

Posted on By

Understanding the Lifecycle of an SOP Document in Pharma Complete Lifecycle Management of SOPs in the Pharmaceutical Industry In the pharmaceutical industry, Standard Operating Procedures (SOPs) are dynamic documents that guide consistent operations and ensure compliance. But SOPs don’t simply get written and forgotten—they follow a structured lifecycle, from drafting to review, implementation, and eventual…

Read More “Understanding the Lifecycle of an SOP Document in Pharma” »

SOP Development, SOP Guidelines

CAPA Risk: Closing Without SOP Revisions

Posted on By

CAPA Risk: Closing Without SOP Revisions When CAPAs Close Without SOP Revisions: A Hidden GMP Breakdown Introduction to the Audit Finding 1. Core Issue Overview In pharmaceutical audits, a common and critical finding is that Corrective and Preventive Actions (CAPAs) are closed without corresponding SOP revisions. 2. Process Breakdown This indicates that the underlying procedural…

Read More “CAPA Risk: Closing Without SOP Revisions” »

CAPA Integration, GMP Audit Findings

GMP Non-Compliance: SOPs Not Updated for Revised Annex 1

Posted on By

GMP Non-Compliance: SOPs Not Updated for Revised Annex 1 Annex 1 Compliance Gaps: Outdated SOPs in Sterile Pharmaceutical Operations Introduction to the Audit Finding 1. Nature of the Gap Standard Operating Procedures (SOPs) in sterile manufacturing were not revised to reflect the latest EU GMP Annex 1 (2022) updates. 2. Significance of Annex 1 (2022)…

Read More “GMP Non-Compliance: SOPs Not Updated for Revised Annex 1” »

GMP Audit Findings, Regulatory Change

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme